Senores Pharmaceuticals Limited has informed that the company will hold an earnings conference call to discuss its Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2025.

• The call is scheduled for Friday, May 16, 2025, at 04:00 P.M. (IST).
• Key company representatives attending the call include Mr. Swapnil Shah (Managing Director), Mr. Sanjay Majmudar (Chairperson), and Mr. Deval Shah (Chief Financial Officer).
• The teleconference will be moderated by Prashant Nair from Ambit Capital.
• Details for joining the call, including primary access numbers and international toll-free numbers, are available.
• Participants are encouraged to use the Diamond Pass for direct access.
• An audio recording and transcript of the call will be subsequently published on the company's website.